Thus, the propensity of drugs to bind to different classes of receptor sites is not only a potentially vexing problem in treating patients, but it also presents a continuing challenge to pharmacology and an opportunity for developing new and more useful drugs.
Brodlie M et al: Targeted therapies to improve CFTR function in cystic fibrosis. Genome Med 2015;7:101. Catterall WA, Swanson TM: Structural basis for pharmacology of voltage-gated sodium and calcium channels. Mol Pharm 2015;88:141. Christopoulos A: Advances in G protein-coupled receptor allostery: From function to structure. Mol Pharmacol 2014;86:463. Dar AC, Shokat KM: The evolution of protein kinase inhibitors from antagonists to agonists of cellular signaling. Ann Rev Biochem 2011;80:7069. Davies MA, Samuels Y: Analysis of the genome to personalize therapy for melanoma. Oncogene 2010;29:5545. Di Fiore PP, von Zastrow M: Endocytosis, signaling, and beyond. Cold Spring Harb Perspect Biol 2014;6:a016865. Esseltine JL, Scott JD: AKAP signaling complexes: Pointing towards the next generation of therapeutic targets? Trends Pharmacol Sci 2013;34:648.
Gouaux E, MacKinnon R: Principles of selective ion transport in channels and pumps. Science 2005;310:1461.
Homan KT, Tesmer JJ: Structural insights into G protein-coupled receptor kinase function. Curr Opin Cell Biol 2014;27:25.
Huang Y et al: Molecular basis for multimerization in the activation of the epidermal growth factor receptor. Elife 2016;5:e14107.
Kang DS, Tian X, Benovic JL: Role of β-arrestins and arrestin domain-containing proteins in G protein-coupled receptor trafficking. Curr Opin Cell Biol 2014;27:63.
Kenakin T, Williams M: Defining and characterizing drug/compound function. Biochem Pharmacol 2014;87:40.
Kho C, Lee A, Hajjar RJ: Altered sarcoplasmic reticulum calcium cycling: Targets for heart failure therapy. Nat Rev Cardiol 2012;9:717.
Kobilka BK: Structural insights into adrenergic receptor function and pharmacology. Trends Pharmacol Sci 2011;32:213.
Liu N et al: microRNA-206 promotes skeletal muscle regeneration and delays progression of Duchenne muscular dystrophy in mice. J Clin Invest 2012;122:2054.
Olson EN: MicroRNAs as therapeutic targets and biomarkers of cardiovascular disease. Sci Transl Med 2014;6:239ps3.
Park HW, Tantisira KG, Weiss ST: Pharmacogenomics in asthma therapy: Where are we and where do we go? Annu Rev Pharmacol Toxicol 2015;55:129.
Quon BS, Rowe SM: New and emerging targeted therapies for cystic fibrosis. Br Med J 2016;352:i859.
Rosell R, Bivona TG, Karachaliou N: Genetics and biomarkers in personalisation of lung cancer treatment. Lancet 2013;382:720.